OUP user menu

Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders

Michele Raja, Antonella Azzoni
DOI: http://dx.doi.org/10.1017/S1461145703003754 409-414 First published online: 1 December 2003


To compare the efficacy of oxcarbazepine (OXC) and valproate (VPA) in the treatment of mood and schizoaffective disorders, we retrospectively analysed data regarding 27 in-patients with mood or schizoaffective diagnosis treated with OXC (and other psychoactive drugs except VPA) and 27 matched in-patients treated with VPA (and other psychoactive drugs except OXC), in a psychiatric intensive care unit of a general hospital. In the evaluation of the outcome, we considered the length of hospitalization, the changes in the scores of BPRS, SAPS, SANS, MMSE, CGI, GAF, UPDRS, BAS, and Morrison's scale. The assessment of global psychopathology and functioning, of positive and mood symptoms suggested similar efficacy of OXC and VPA. Unexpectedly, OXC appeared more efficacious in the treatment of negative symptoms.

Key words
  • Bipolar disorder
  • oxcarbazepine
  • schizoaffective disorder
  • treatment
  • valproate